Breast Imaging

Mammography AI approach finds more breast cancers, reduces workload
By Amerigo Allegretto
An AI approach that excludes low-risk mammograms from radiologist reading led to more cancers being found.
March 19, 2026
Breast Cancer 3 D 400
The future of BI-RADS includes AI
By Amerigo Allegretto
A presentation given at ECR 2026 outlined how AI-driven BI-RADS will further improve breast cancer risk assessment.
March 10, 2026
Dr. Linda Moy.
AI-calculated BAC on mammograms predicts cardiovascular disease in women
By Amerigo Allegretto
AI-calculated breast arterial calcification (BAC) on mammograms could help predict cardiovascular disease risk in women.
March 9, 2026
2026 03 09 Ehj Bac Mammograms Ai V2 Thumbnail3
ECR: Imaging biomarker studies need stronger quality assurance
By Liz Carey
Prof. Fiona Gilbert shares lessons learned from two important studies.
March 6, 2026
Ecr 2026 Sign
Lancet Oncology: Global breast cancer cases could surge to 3.5M by 2050
By Kate Madden Yee
The study also found that yearly deaths could increase by 44%, climbing from 764,000 in 2023 to nearly 1.4 million in 2050.
March 3, 2026
Graph Arrow Up 400
Mammography screening improves survival for late-stage cancers
By Amerigo Allegretto
Women with screen-detected late-stage cancer have greater survival compared with women who do not undergo mammography screening.
February 23, 2026
Mammogram Dense Breasts Cropped
German team unveils dose findings on breast MRI
By Kate Madden Yee
Breast MRI using gadopiclenol with a half gadolinium dose offers equivalent to superior contrast enhancement compared to gadobutrol-enhanced MRI with full gadolinium dose.
February 9, 2026
Mri Breast Cancer
Audit puts spotlight on breast density in women under 50
By Philip Ward
A 12-year audit conducted at a women’s imaging facility has provided new data on the link between mammographic breast density and cancer detection in younger patients.
February 5, 2026
Right breast, 10 o’clock position, same patient: A 15 mm irregular hypoechoic solid lesion with suspicious morphology, situated approximately 6 mm from the index lesion. Biopsy confirmed invasive ductal carcinoma, Grade 2, ER positive, PR positive, HER2 positive, concordant with ultrasound features. Findings are in keeping with multifocal invasive ductal carcinoma in a heterogeneously dense breast. The patient was referred for surgical management.
DBT shows advantages over mammography in TMIST Lead-in analysis
By Amerigo Allegretto
DBT could improve screening performance over conventional mammography in age groups not eligible for the TMIST study.
February 4, 2026
Breast Tomosynthesis Digital Social
QT Imaging, Olea Medical partner on multimodal breast imaging
By AuntMinnieEurope.com staff writers
Olea Medical's technology will be integrated with QT Imaging's breast imaging platform as QT Imaging Olea Vision software.
February 2, 2026
Breast Imaging Computer Screen Thumbnail
AI-mammography finds more interval cancers, cuts workload
By Amerigo Allegretto
AI-supported mammography leads to more positive outcomes for women compared with standard double reading, a new European study has found.
January 30, 2026
Breast Mammo Computer
ESR reveals plans for 3 organ-based scientific journals
By Liz Carey
The European Society of Radiology (ESR) is moving ahead with plans to publish three new organ-based spinoff scientific journals.
January 26, 2026
Thumb For Ecr 2025 Attendance Figs
Page 1 of 141
Next Page